El Nile for Pharmaceuticals' (NIPH)
announced, in a statement sent to EGX, the Board of Directors (BoD) held on Jan. 21.
The company's BoD approved financial results for the fiscal period ending Dec. 31, 2019, which revealed posting after-tax profits of EGP 34.904 million, versus incurring losses of EGP 5.150 million a year earlier, with a 777% profit increase.
Copyright © 2020 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).